Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Lemzoparlimab (DHG17603)

Host species:Humanized
Isotype:IgG4-Kappa
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DHG17603

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

IgG4-Kappa

Clonality

Monoclonal

Target

Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q08722

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

CD47, TJ-011133, TJC-4, CAS: 2377483-71-9

Clone ID

Lemzoparlimab

Data Image
  • SDS-PAGE
    SDS PAGE for Lemzoparlimab
  • Bioactivity
    Detects CD47/MER6 in indirect ELISAs.
References

CD47 does not mediate amyloid-beta(1-42) protofibril-stimulated microglial cytokine release. PMID: 25451248

Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation. PMID: 30569825

Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer. PMID: 28351890

Donor CD47 controls T cell alloresponses and is required for tolerance induction following hepatocyte allotransplantation. PMID: 27230788

CD47 signaling regulates the immunosuppressive activity of VEGF in T cells. PMID: 25200950

Role of Erythrocyte CD47 in Intracerebral Hematoma Clearance. PMID: 26732568

CD47(high) expression on CD4 effectors identifies functional long-lived memory T cell progenitors. PMID: 22461697

Blocking CD47 shrinks pancreatic tumors. PMID: 25092731

RRx-001, a downregulator of the CD47- SIRPalpha checkpoint pathway, does not cause anemia or thrombocytopenia. PMID: 33432831

Single-cell RNA sequencing study of retinal immune regulators identified CD47 and CD59a expression in photoreceptors-Implications in subretinal immune regulation. PMID: 32166783

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. PMID: 30056566

Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties. PMID: 26172292

Targeting CD47 Enhances the Efficacy of Anti-PD-1 and CTLA-4 in an Esophageal Squamous Cell Cancer Preclinical Model. PMID: 28337964

CD47 blockade as another immune checkpoint therapy for cancer. PMID: 26444633

Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity. PMID: 32503944

Purification of CD47-streptavidin fusion protein from bacterial lysate using biotin-agarose affinity chromatography. PMID: 27110670

Novel CD47-dependent intercellular adhesion modulates cell migration. PMID: 15880429

CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis. PMID: 26010544

CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice. PMID: 22870271

Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation. PMID: 18394962

On the mechanism of CD47 targeting in cancer. PMID: 22923695

The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. PMID: 22266027

Alternative 3' UTRs act as scaffolds to regulate membrane protein localization. PMID: 25896326

Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy. PMID: 32658476

Datasheet

Document Download

Research Grade Lemzoparlimab.pdf

 

$ 328
Product specifications
100 μg 328 1 mg 1314

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Lemzoparlimab [DHG17603]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only